Platelet-Rich Plasma (PRP) Preparation Standardization
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy adult volunteers aged 18 to 60 years. 2. Individuals who provide written informed consent. 3. Participants with normal baseline complete blood count (CBC) parameters. 4. Non-smokers or light smokers (to reduce variables affecting blood quality). 5. Not currently on medications that affect platelet function (e.g., NSAIDs, antiplatelets, anticoagulants).
Exclusion criteria
Exclusion criteria: 1. History of hematological disorders (e.g., thrombocytopenia, anemia, coagulopathies). 2. Active infection, inflammation, or chronic illness (e.g., diabetes, autoimmune disease). 3. Use of antiplatelet, anticoagulant, or anti-inflammatory medications within the last 7 days. 4. Pregnancy or breastfeeding. 5. Recent history of blood donation (within 8 weeks). 6. Inability or unwillingness to comply with study procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet Concentration in PRP will be measured using an automated hematology analyzer | — |
Secondary
| Measure | Time frame |
|---|---|
| Relative Centrifugal Force (RCF or g-force)will be calculated | — |
Countries
Asia(except Japan)
Contacts
Combined Military Hospital Kohat KPK Pakistan Department of Physical Medicine and Rehabilitation